LSD 220µg Blotter Sheets, commonly known as acid, is a hallucinogenic compound that alters perception, mood, and awareness. The Lysergic acid diethylamide (LSD) 220ug represents a widely recognized format, where the compound is absorbed into perforated paper units for consistent distribution.
Order LSD blotters sheet online
Chemical Properties
In its pure state, LSD appears colorless or white, odorless, and crystalline. However, it remains highly sensitive to ultraviolet light and degrades when exposed. The compound originates from lysergic acid, which is derived from the ergot fungus.
Pharmacological Activity
LSD primarily interacts with the serotonin system, particularly receptors linked to cognition and perception. As a result, even low doses, starting around 20 micrograms, can produce noticeable effects. After oral administration, effects typically begin within 30 to 45 minutes, peak between 2 and 4 hours, and may persist for up to 12 hours.
Effects Profile
LSD 220µg Blotter Sheets Reported effects include visual distortions, altered perception of colors and shapes, and changes in auditory processing. In addition, cognitive effects often involve thought acceleration, enhanced introspection, and altered time perception.
Physical responses may include pupil dilation, increased heart rate, elevated blood pressure, and a rise in body temperature. However, intensity varies depending on dose, environment, and individual sensitivity.
Forms and Distribution
LSD most commonly appears on blotter paper. However, it also exists in gelatin squares, tablets (microdots), capsules, and liquid forms applied to sugar cubes. Pure liquid LSD is highly potent and requires precise handling.
Scientific Context and Risk Profile
LSD does not typically produce physical dependence, although tolerance may develop with repeated use. However, adverse psychological effects can occur, including anxiety, paranoia, and delusional states. In some cases, individuals report persistent perceptual disturbances known as hallucinogen persisting perception disorder (HPPD).
The compound was first synthesized by Albert Hofmann in 1938, with psychoactive effects identified in 1943. It was later classified as a controlled substance under international regulations.




Reviews
There are no reviews yet.